Z-1091-2017 Class II Terminated
FDA device recall Z-1091-2017 was initiated by Merge Healthcare, Inc. on Mar 28, 2016 and is designated Class II. Reason for recall: There is a potential connection issue when powering up the Merge Hemo Record Station and the Hemo Monitor does not communicate with the Client PC. The recall status is terminated (terminated Jun 28, 2019). Affected quantity: 242 sites potentially have the affected versions.
Recall details
- Product Type
- Devices
- Report Date
- Feb 1, 2017
- Initiation Date
- Mar 28, 2016
- Termination Date
- Jun 28, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 242 sites potentially have the affected versions
Product description
Merge Hemo software. Merge Hemo monitors, measures, and records physiologic data from a human patient undergoing a cardiac catheterization procedure
Reason for recall
There is a potential connection issue when powering up the Merge Hemo Record Station and the Hemo Monitor does not communicate with the Client PC.
Distribution pattern
Nationwide Distribution
Code information
Versions 6.10, 6.10.1, 6.10.2, 6.10.3, 7.10, 7.20, 7.20.1, 8.10.0, 8.20, 9.10.0, 9.20, 9.20.2, 9.20.3, 9.30, 9.40, 9.40.1, 9.40.2, and 9.40.3
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1091-2017
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026